EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Naloxone Administration in Relation to Fentanyl, Xylazine, CNS Depressants, and Stimulants Exposure After Suspected Opioid Overdose: A Pilot Study

Roland C Merchant, Brittany Chapman, Patricia Mae Martinez, Alex Krotulski, Sara Walton, Carmen Vargas-Torres, John Broach, Kavita M Babu

Academic Emergency Medicine · 2026-04 · 33 (4)

DOI: 10.1111/acem.70280 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Academic Emergency Medicine, online erschienen am 03.04.2026. Verfasst von Roland C Merchant und 7 weiteren Autor:innen. Beteiligte Einrichtung: Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Naloxone, Fentanyl, Narcotic Antagonists, Xylazine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In this pilot, observational study, we characterized naloxone doses individuals received after suspected opioid overdoses in comparison to concentrations of fentanyl, xylazine, central nervous system (CNS) depressants, and stimulants detected in their blood.

Methods

Adults (≥ 18 years old) with suspected opioid overdose presenting to two academic urban US emergency departments (EDs) were recruited between October 2022 and January 2025. Naloxone parenteral equivalents administered prior to ED arrival were compared to fentanyl and xylazine as well as to CNS depressant (e.g., benzodiazepines) and stimulant (e.g., cocaine) blood concentrations.

Results

Of the 106 participants, 72% had detectable concentrations of fentanyl; 49% xylazine; 44% CNS depressants; and 74% stimulants. Total mean naloxone parenteral equivalents administered were 3.45 mg (SD 2.13), median 4.0 (IQR 2–4), and mean first dose was 1.98 (SD 1.1), median 2.0 (IQR 2–2). Xylazine concentrations increased moderately as fentanyl concentrations increased (Spearman ρ = 0.45, p < 0.001). Participants whose fentanyl concentrations were in the 4th quartile had received more naloxone (4.67 mg) than those with fentanyl concentrations in the 3rd, 2nd, and 1st quartiles (4.67, 3.22, and 2.74 mg of naloxone, respectively) ( p < 0.01 for all comparisons). Of the 52 participants exposed to xylazine, those with xylazine concentrations in the 4th quartile generally had received more naloxone (5.03 mg) than those in the 3rd, 2nd, and 1st xylazine quartiles (3.35, 2.92, and 3.27 mg of naloxone, respectively), but these comparisons did not reach statistical significance ( p > 0.05).

Conclusions

The typical dose of naloxone needed in suspected opioid overdoses within a fentanyl endemic area was 4 mg. This dose was similar when xylazine co‐exposure occurred, although it tended to be higher with higher xylazine concentrations detected. However, fentanyl was also present at higher levels when greater amounts of xylazine were present.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaloxoneFentanylNarcotic AntagonistsXylazineOpiate OverdoseCentral Nervous System StimulantsDrug OverdoseHumansPilot ProjectsFemaleAdultMaleEmergency Service, HospitalAnalgesics, OpioidMiddle Aged

Substanzen

NaloxoneFentanylNarcotic AntagonistsXylazineCentral Nervous System StimulantsAnalgesics, Opioid

Autor:innen und Institutionen

  • Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
  • Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, Pennsylvania, USA.

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Merchant, R. C., Chapman, B., Martinez, P. M., Krotulski, A., Walton, S., Carmen Vargas-Torres, Broach, J., & Babu, K. M. (2026). Naloxone Administration in Relation to Fentanyl, Xylazine, CNS Depressants, and Stimulants Exposure After Suspected Opioid Overdose: A Pilot Study. Academic Emergency Medicine, 33(4). https://doi.org/10.1111/acem.70280

Vancouver

Merchant RC, Chapman B, Martinez PM, Krotulski A, Walton S, Carmen Vargas-Torres, et al. Naloxone Administration in Relation to Fentanyl, Xylazine, CNS Depressants, and Stimulants Exposure After Suspected Opioid Overdose: A Pilot Study. Academic Emergency Medicine. 2026;33(4). doi:10.1111/acem.70280

BibTeX
@article{Merchant2026,
  author = {Merchant, Roland C and Chapman, Brittany and Martinez, Patricia Mae and Krotulski, Alex and Walton, Sara and Carmen Vargas-Torres and Broach, John and Babu, Kavita M},
  title = {Naloxone Administration in Relation to Fentanyl, Xylazine, CNS Depressants, and Stimulants Exposure After Suspected Opioid Overdose: A Pilot Study},
  journal = {Academic Emergency Medicine},
  year = {2026},
  volume = {33},
  number = {4},
  doi = {10.1111/acem.70280}
}
Kostenlos starten →